GSK acquires stake in Novartis’s consumer healthcare business
Date: 2018-03-28   Author: Dhananjay Punekar  Category: #market

GSK acquires stake in Novartis’s consumer healthcare business

GlaxoSmithKline, a renowned pharmaceutical giant, has announced that it will acquire 36.5% of the ownership rights in Novartis’s consumer healthcare venture for USD 13 billion in cash.  For the record, last week, GSK withdrew its acquisition bid for Pfizer’s consumer healthcare business through which it had expected to accrue nearly USD 20 billion in terms of revenue. Currently though, GSK is anticipated to take complete control of Novartis’s venture, including the Sensodyne toothpaste, Nicotinell patches, Panadol headache medicines, and muscle gel Voltaren.

Emma Walmsley, the CEO of GlaxoSmithKline has stated that the proposed deal will help in addressing the firm’s key capital allocation priorities and help GSK investors in realizing the complete value of the leading consumer healthcare firm. The move will increase adjusted earnings and cash flows resulting in the improved performance for the company, she says. Further on, Walmsley adds that the deal would help the organization invest its capital in other activities such as pharmaceuticals R&D.

As per reliable sources, this pact is expected to be finalized during the second quarter of this year subject to the necessary approvals. Vas Narasimhan, the CEO of Novartis, has said that the firm is likely to divest one of its many non-core assets at a rather lucrative price.

According to an official statement, Novartis will use the proceeds from the deal for expanding its business and for the bolt-on acquisitions. After the declaration, the firm has incidentally witnessed a 2.2% rise in the pre-market indications in Zurich.

GSK has announced that it will review Horlicks and other consumer nutrition products, which will also include an assessment of the share it holds in its Indian subsidiary - GSK Consumer Healthcare Limited. It has been speculated that numerous other pharma firms are likely to follow GSK’s footsteps, which would eventually support the expansion of the global consumer healthcare business.



About Author


Dhananjay Punekar

Dhananjay Punekar

Dhananjay currently works as a content writer at AlgosOnline. A post graduate in mathematics as well as business administration, he worked as a process executive in Infosys BPO Limited before switching his professional genre. Following his childhood passion, he opted fo...

Read More

More from Dhananjay


Post Recommendents

WAN Edge Infrastructure Market, Share, Application Analysis, Regional Outlook, Competitive Strategies & Forecast up to 2024
Author: Partha Ray

Market Study Report, LLC, has expanded its reports' database with a new research study on ' WAN Edge Infrastructure market' which features a precise summary of the business valuation, SWOT Analysis, market size, revenue estimation and ...


Vulnerability Assessment Solutions Market to witness high growth in near future
Author: Partha Ray

Market Study Report, LLC, has added a research study on ' Vulnerability Assessment Solutions market' which offers a concise summary regarding market valuation, market share, regional spectrum, revenue estimation and SWOT analysis of this b...


Global Utilities Customer Information Systems Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2024
Author: Partha Ray

The ' Utilities Customer Information Systems market' study Added by Market Study Report, LLC, delivers an in-depth outline regarding the powerful trends existing within the industry. The study also comprises significant information concern...